Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) Butanoic Acid
2. K 13675
3. K-13675
4. K-13675-d11
5. K-13675-d7
6. K13675
1. 848259-27-8
2. Pemafibrate [inn]
3. (r)-k-13675
4. K-13675, (r)-
5. (r)-2-(3-((benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic Acid
6. Chembl247951
7. Cas#848259-27-8
8. 17vgg92r23
9. Pemafibrate (jan)
10. Pemafibrate [jan]
11. (2r)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic Acid
12. (2~{r})-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic Acid
13. Unii-17vgg92r23
14. Parmodia (tn)
15. P7f
16. Pemafibrate [mi]
17. K-877
18. (r)-k 13675
19. Pemafibrate [who-dd]
20. Schembl2766188
21. Dtxsid00233891
22. Glxc-25532
23. Bcp20864
24. Ex-a1919
25. Yib25927
26. Bdbm50214899
27. Cs-6084
28. Db15212
29. Ac-36249
30. Hy-17618
31. D10711
32. A914970
33. (r)-k-13675(r)-k-13675
34. Q27251943
35. K-877; (r)-k 13675; Cs-2768
36. K-877; K877; K 877; (r)-k 13675; (r)-k13675; (r)k-13675
37. (r)-2-(3-((n-(benzoxazol-2-yl)-n-(3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic Acid
38. (r)-2-[3-[n-(benzoxazol-2-yl)-n-(3-(4-methoxyphenoxy)propyl)aminomethyl]phenoxy]butyric Acid
Molecular Weight | 490.5 g/mol |
---|---|
Molecular Formula | C28H30N2O6 |
XLogP3 | 6.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 13 |
Exact Mass | 490.21038668 g/mol |
Monoisotopic Mass | 490.21038668 g/mol |
Topological Polar Surface Area | 94.3 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 658 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Prevention of cardiovascular events in patients with elevated triglycerides levels, Treatment of hypertriglyceridaemia
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
52
PharmaCompass offers a list of Pemafibrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pemafibrate manufacturer or Pemafibrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pemafibrate manufacturer or Pemafibrate supplier.
PharmaCompass also assists you with knowing the Pemafibrate API Price utilized in the formulation of products. Pemafibrate API Price is not always fixed or binding as the Pemafibrate Price is obtained through a variety of data sources. The Pemafibrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pemafibrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pemafibrate, including repackagers and relabelers. The FDA regulates Pemafibrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pemafibrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pemafibrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pemafibrate supplier is an individual or a company that provides Pemafibrate active pharmaceutical ingredient (API) or Pemafibrate finished formulations upon request. The Pemafibrate suppliers may include Pemafibrate API manufacturers, exporters, distributors and traders.
click here to find a list of Pemafibrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pemafibrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pemafibrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pemafibrate GMP manufacturer or Pemafibrate GMP API supplier for your needs.
A Pemafibrate CoA (Certificate of Analysis) is a formal document that attests to Pemafibrate's compliance with Pemafibrate specifications and serves as a tool for batch-level quality control.
Pemafibrate CoA mostly includes findings from lab analyses of a specific batch. For each Pemafibrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pemafibrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pemafibrate EP), Pemafibrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pemafibrate USP).